Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724) (Supportive Care in Cancer, (2021), 29, 2, (833-840), 10.1007/s00520-020-05543-5)

Costantine Albany; Travis Dockter; Eric Wolfe; Jennifer Le-Rademacher; Nina Wagner-Johnston; Lawrence Einhorn; Jacqueline M. Lafky; Ellen Smith; Deirdre Pachman; Nathan Staff; Cynthia Ma; Charles L. Loprinzi; Brian A. Costello

doi:10.1007/s00520-021-06523-z

Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724) (Supportive Care in Cancer, (2021), 29, 2, (833-840), 10.1007/s00520-020-05543-5)

Costantine Albany, Travis Dockter, Eric Wolfe, Jennifer Le-Rademacher, Nina Wagner-Johnston, Lawrence Einhorn, Jacqueline M. Lafky, Ellen Smith, Deirdre Pachman, Nathan Staff, Cynthia Ma, Charles L. Loprinzi, Brian A. Costello

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

After publication of the article [1], the authors identified errors in Fig. 5. Specifically, the two curves regarding paclitaxel/ CBDCA and paclitaxel were incorrect in the latter time periods. The corrected version of Fig. 5 is provided here.

Original language	English (US)
Pages (from-to)	7129-7130
Number of pages	2
Journal	Supportive Care in Cancer
Volume	29
Issue number	11
DOIs	https://doi.org/10.1007/s00520-021-06523-z
State	Published - Nov 2021

ASJC Scopus subject areas

Oncology

Access to Document

10.1007/s00520-021-06523-z

Fingerprint

Dive into the research topics of 'Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724) (Supportive Care in Cancer, (2021), 29, 2, (833-840), 10.1007/s00520-020-05543-5)'. Together they form a unique fingerprint.

Cite this

Albany, C., Dockter, T., Wolfe, E., Le-Rademacher, J., Wagner-Johnston, N., Einhorn, L., Lafky, J. M., Smith, E., Pachman, D., Staff, N., Ma, C., Loprinzi, C. L., & Costello, B. A. (2021). Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724) (Supportive Care in Cancer, (2021), 29, 2, (833-840), 10.1007/s00520-020-05543-5). Supportive Care in Cancer, 29(11), 7129-7130. https://doi.org/10.1007/s00520-021-06523-z

Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724) (Supportive Care in Cancer, (2021), 29, 2, (833-840), 10.1007/s00520-020-05543-5). / Albany, Costantine; Dockter, Travis; Wolfe, Eric et al.
In: Supportive Care in Cancer, Vol. 29, No. 11, 11.2021, p. 7129-7130.

Research output: Contribution to journal › Comment/debate › peer-review

Albany, C, Dockter, T, Wolfe, E, Le-Rademacher, J, Wagner-Johnston, N, Einhorn, L, Lafky, JM, Smith, E, Pachman, D, Staff, N, Ma, C, Loprinzi, CL & Costello, BA 2021, 'Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724) (Supportive Care in Cancer, (2021), 29, 2, (833-840), 10.1007/s00520-020-05543-5)', Supportive Care in Cancer, vol. 29, no. 11, pp. 7129-7130. https://doi.org/10.1007/s00520-021-06523-z

Albany C, Dockter T, Wolfe E, Le-Rademacher J, Wagner-Johnston N, Einhorn L et al. Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724) (Supportive Care in Cancer, (2021), 29, 2, (833-840), 10.1007/s00520-020-05543-5). Supportive Care in Cancer. 2021 Nov;29(11):7129-7130. doi: 10.1007/s00520-021-06523-z

@article{ffd6b1e27af443d9a787dccf2cbbadca,

title = "Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724) (Supportive Care in Cancer, (2021), 29, 2, (833-840), 10.1007/s00520-020-05543-5)",

abstract = "After publication of the article [1], the authors identified errors in Fig. 5. Specifically, the two curves regarding paclitaxel/ CBDCA and paclitaxel were incorrect in the latter time periods. The corrected version of Fig. 5 is provided here.",

author = "Costantine Albany and Travis Dockter and Eric Wolfe and Jennifer Le-Rademacher and Nina Wagner-Johnston and Lawrence Einhorn and Lafky, {Jacqueline M.} and Ellen Smith and Deirdre Pachman and Nathan Staff and Cynthia Ma and Loprinzi, {Charles L.} and Costello, {Brian A.}",

note = "Publisher Copyright: {\textcopyright} 2021, Springer-Verlag GmbH Germany, part of Springer Nature",

year = "2021",

month = nov,

doi = "10.1007/s00520-021-06523-z",

language = "English (US)",

volume = "29",

pages = "7129--7130",

journal = "Supportive Care in Cancer",

issn = "0941-4355",

publisher = "Springer Verlag",

number = "11",

}

TY - JOUR

T1 - Correction to

T2 - Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724) (Supportive Care in Cancer, (2021), 29, 2, (833-840), 10.1007/s00520-020-05543-5)

AU - Albany, Costantine

AU - Dockter, Travis

AU - Wolfe, Eric

AU - Le-Rademacher, Jennifer

AU - Wagner-Johnston, Nina

AU - Einhorn, Lawrence

AU - Lafky, Jacqueline M.

AU - Smith, Ellen

AU - Pachman, Deirdre

AU - Staff, Nathan

AU - Ma, Cynthia

AU - Loprinzi, Charles L.

AU - Costello, Brian A.

PY - 2021/11

Y1 - 2021/11

N2 - After publication of the article [1], the authors identified errors in Fig. 5. Specifically, the two curves regarding paclitaxel/ CBDCA and paclitaxel were incorrect in the latter time periods. The corrected version of Fig. 5 is provided here.

AB - After publication of the article [1], the authors identified errors in Fig. 5. Specifically, the two curves regarding paclitaxel/ CBDCA and paclitaxel were incorrect in the latter time periods. The corrected version of Fig. 5 is provided here.

UR - http://www.scopus.com/inward/record.url?scp=85114192469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85114192469&partnerID=8YFLogxK

U2 - 10.1007/s00520-021-06523-z

DO - 10.1007/s00520-021-06523-z

M3 - Comment/debate

C2 - 34480623

AN - SCOPUS:85114192469

SN - 0941-4355

VL - 29

SP - 7129

EP - 7130

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

IS - 11

ER -

Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724) (Supportive Care in Cancer, (2021), 29, 2, (833-840), 10.1007/s00520-020-05543-5)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this